Skip to main content
. 2016 Nov 14;2016:6064830. doi: 10.1155/2016/6064830

Figure 1.

Figure 1

Serum levels of active TGF-β1 in healthy controls (HC), systemic sclerosis (SSc) patients, diffuse cutaneous systemic sclerosis (dSSc) patients, and limited cutaneous systemic sclerosis (lSSc) patients. Short horizontal bars represent median.  ∗∗ p = 0.001,  ∗∗∗ p < 0.0001, and ns = not significant.